Transparency Market Research Bone Morphogenetic Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 – 2022
Published Date 2015-04-23
65 Page Report
Buy Now
Request Sample
Press Release
Bone Morphogenetic Proteins Market Expected to Reach USD 587.069 Million Globally in 2022 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Platelet Rich Plasma Market
REPORT DESCRIPTION
Bone Morphogenetic Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 – 2022 To date, autograft bone graft substitutes harvested from the patient’s own body and allografts harvested from human cadaver or animal are considered ideal for healing injured bone tissues. Although, autologus and allogenic bone grafting is an effective treatment of certain spinal disorders, the bone transplantation procedure could prolong hospital stay, increase blood loss, recovery time, risk of infectious disease transmission, and increased stress at the harvest site. Furthermore, autografts are not suitable for elderly patients and allogenic bone grafts in some cases show low bio-activity level. Thus, bone grafting procedures are witnessing a steady shift from allogenic and autologus bone graft substitutes to growth factors such as bone morphogenetic proteins (BMPs) and cell-based matrices. BMPs have the ability to stimulate new bone formation by initiating the differentiation of stem cells into osteoblasts. The BMP products have eliminated the need for bone harvesting and reduced the healing time. Thus, the market for BMPs is increasing owing to better osteoinduction and fusion rate, which have reduced the hospital stay, consequently reducing the overhead expenses.
Browse the full Bone Morphogenetic Proteins Market Report @ : http://www.transparencymarketresearch.com/bone-morphogeneticprotein-market.html The global bone morphogenetic proteins market, based on geography, is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). In 2013, North America accounted for the majority share of this market globally in terms of revenue and is anticipated to retain its position during the forecast period. Growth in this market is expected to be driven by aging population and the desire to have an active lifestyle. Similarly, increasing incidences of lower back pain, which is commonly observed in people aged between 40 years and 80 years, is also a key factor that is expected to increase the uptake of BMPs in North America. According to the National Institutes of Health statistics, lower back pain was the most common cause of pain, followed by migraine or headache, and neck pain in the U.S. in 2012. Moreover, 28.4% of the population of the U.S. visits physician clinics for chronic lower back pain. Lower back pain is associated common reason for missed work and job-related disability. Thus, patients with back pain are advised spinal fusion procedures, if non-surgical treatment is ineffective. Therefore, growing incidences of lower back pain that requires spinal surgeries is expected to propel
Transparency Market Research
2
Platelet Rich Plasma Market
demand for bone morphogenetic proteins in North America. Furthermore, in North America spinal fusion surgeries accounted for the largest share of the market at 76.5% in 2013. In addition, according to the Agency for Healthcare Research and Quality (AHRQ), the number of spinal fusion procedures in the U.S. increased by 72% from 2002 (260,000) to 2011 (460,000). The European region followed the North America bone morphogenetic proteins market globally in 2013.
Browse the full Bone Morphogenetic Proteins Market Press Release @ : http://www.transparencymarketresearch.com/pressrelease/bonemorphogenetic-protein-market.htm The most promising growth in this market is expected to emerge from the Asia-Pacific region due to rising geriatric population, which is more prone to orthopedic disorders and requires urgent effective care. In addition, the rapidly evolving medical tourism industry in countries such as India, Thailand, and Singapore, rise in disposable income, and growing awareness about orthopedic treatment are few key reasons that are anticipated to propel growth of the BMP market in this region. The BMP market in RoW is underdeveloped and has not expanded due to high cost, reimbursement challenges, and inadequate training of surgeons. Adverse side effects associated with BMP usage have also restricted the uptake of BMPs in these regions. The market for bone morphogenetic proteins is emerging and is currently occupied by only two players, Medtronic plc and Olympus Biotech Corporation. Of the two, in 2013 Medtronic held the lion’s share due to wide usage of INFUSE. On the other hand, Olympus Biotech accounted for less than 7% of the global BMP market. This is because OP-1/Opgenra is approved for cases, where autologus bone marrow harvesting is not possible or other treatments have failed.
Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=2308 The global bone morphogenetic proteins market is segmented as follows: Global Bone Morphogenetic Proteins Market Revenue, by Types •
rhBMP-2
•
rhBMP-7
Global Bone Morphogenetic Proteins Market Revenue, by Application
Transparency Market Research
3
Platelet Rich Plasma Market
•
Spinal Fusion
•
Trauma
•
Reconstructive Surgery
•
Oral-Maxillofacial
Global Bone Morphogenetic Proteins Market Revenue, by Geography North America •
Types
•
Applications
Europe •
Types
•
Applications
Asia Pacific •
Types
•
Applications
RoW •
Types
•
Applications
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation
Transparency Market Research
4
Platelet Rich Plasma Market
1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.4 Assumptions
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Bone Morphogenetic Proteins Market (2013 & 2022) 2.2 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2013 (USD Million) 2.3 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2013 (USD Million) 2.4 Comparative Analysis: Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2013 & 2022 (Value %)
Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Increase in number of spinal fusion surgeries would expedite the demand of BMPs 3.2.2 Aging population likely to trigger the demand for bone morphogenetic proteins 3.2.3 Surge in trauma and sports related injuries 3.2.4 Increasing prevalence of lower back pain would increase the number of spinal surgeries 3.2.5 Rising demand for minimally invasive surgeries
Transparency Market Research
5
Platelet Rich Plasma Market
3.3 Market Restraints 3.3.1 Off-label usage linked with serious side effects leads to decline in market revenue 3.3.2 Availability of alternative bone graft substitutes reduces the demand of BMPs 3.3.3 High cost of BMPs and approval for limited indications limits the market earning 3.4 Market Opportunities 3.4.1 Emerging countries 3.5 Porter’s Five Force Analysis: Global Bone Morphogenetic Proteins Market 3.5.1 Bargaining power of suppliers 3.5.2 Bargaining power of buyers 3.5.3 Threat of new entrants 3.5.4 Threat of substitutes 3.5.5 Competitive rivalry 3.6 Market Attractiveness Analysis: Global Bone Morphogenetic Proteins Market, by Geography, 2013 3.7 Regulatory Framework 3.8 Value Chain Analysis 3.9 Competitive Landscape 3.9.1 Global Bone Morphogenetic Proteins Market Share Analysis, by Key Players, 2013 (Value %) 3.10 Global Orthobiologics Market Revenue, by Types, 2012 – 2022 (USD Million)
Transparency Market Research
6
Platelet Rich Plasma Market
Chapter 4 Bone Morphogenetic Proteins Market, by Types 4.1 Overview 4.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) 4.2 Average Pricing Analysis 4.3 Recombinant human bone morphogenetic protein-2 (rhBMP-2) 4.3.1 Global rhBMP-2 Market Revenue, 2012 – 2022 (USD Million) 4.4 Recombinant human bone morphogenetic protein-7 (rhBMP-7) 4.4.1 Global rhBMP-7 Market Revenue, 2012 – 2014 (USD Million)
Chapter 5 Bone Morphogenetic Proteins Market, by Application 5.1 Overview 5.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) 5.2 Spinal Fusion 5.2.1 Global Spinal Fusion Market Revenue,2012–2022 (USD Million) 5.3 Trauma 5.3.1 Global Trauma Market Revenue,2012–2022 (USD Million) 5.4 Reconstructive Surgery 5.4.1 Global Reconstructive Surgery Market Revenue,2012–2022 (USD Million) 5.5 Oral-Maxillofacial
Transparency Market Research
7
Platelet Rich Plasma Market
5.5.1 Global Oral-Maxillofacial Market Revenue,2012–2022 (USD Million)
Chapter 6 Bone Morphogenetic Proteins Market, by Geography 6.1 Overview 6.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2012 – 2022 (USD Million) 6.2 North America 6.2.1 North America Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) 6.2.2 North America Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) 6.3 Europe 6.3.1 Europe Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) 6.3.2 Europe Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) 6.4.2 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) 6.5 Rest of the World
Transparency Market Research
8
Platelet Rich Plasma Market
6.5.1 RoW Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) 6.5.2 RoW Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
Chapter 7 Recommendation 7.1 Success strategies 7.1.1 Introduction of new indication, carriers and formulations for BMP products 7.1.2 Investing in emerging economies
Chapter 8 Company Profiles 8.1 Cellumed Co, Ltd. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Medtronic plc 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio
Transparency Market Research
9
Platelet Rich Plasma Market
8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Stryker Corporation 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments List of Figures
FIG. 1 Bone Morphogenetic Proteins: Market Segmentation FIG. 2 Global Bone Morphogenetic Proteins Market, by Types, 2013 (USD Million) FIG. 3 Global Bone Morphogenetic Proteins Market, by Applications, 2013 (USD Million) FIG. 4 Comparative Analysis: Global Bone Morphogenetic Proteins Revenue, by Geography, 2013 & 2022 (Value %) FIG. 5 Porter’s Five Force Analysis: Global Bone Morphogenetic Proteins Market FIG. 6 Market Attractiveness Analysis: Global Bone Morphogenetic Proteins Market, by Geography FIG. 7 Value Chain: Global Bone Morphogenetic Proteins Market FIG. 8 Global Bone Morphogenetic Protein Market Share Analysis, by Key Players, 2013 (Value %) FIG. 9 Global rhBMP-2 Market Revenue, 2012 - 2022 (USD Million)
Transparency Market Research
10
Platelet Rich Plasma Market
FIG. 10 Global rhBMP-7 Market Revenue, 2012 - 2014 (USD Million) FIG. 11 Global Spinal Fusion Market Revenue, 2012 – 2022 (USD Million) FIG. 12 Global Trauma Market Revenue, 2012 – 2022 (USD Million) FIG. 13 Global Reconstructive Surgery Market Revenue, 2012 – 2022 (USD Million) FIG. 14 Global Oral-Maxillofacial Market Revenue, 2012 – 2022 (USD Million) FIG. 15 Medtronic, Inc.: Annual Revenue, 2012 - 2014 (USD Million) FIG. 16 Stryker Corporation: Annual Revenue, 2012– 2014 (USD Million) List of Tables
TABLE 1 Market Snapshot: Global Bone Morphogenetic Proteins Market (2013 & 2022) TABLE 2 Global Orthobiologics Market Revenue, by Types, 2012 – 2022 (USD Million) TABLE 3 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) TABLE 4 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) TABLE 5 Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2012 – 2022 (USD Million) TABLE 6 North America Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) TABLE 7 North America Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) TABLE 8 Europe Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
Transparency Market Research
11
Platelet Rich Plasma Market
TABLE 9 Europe Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) TABLE 10 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) TABLE 11 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million) TABLE 12 RoW Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million) TABLE 13 RoW Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
12
Platelet Rich Plasma Market
Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
13